December 16, 2025
December 02, 2025
FDA Approves Amneal’s Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye
December 02, 2025
FDA Approves Amneal’s Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye
December 01, 2025
Belite Bio Reports Positive Phase 3 Results of Tinlarebant in Adolescents With Stargardt Disease
December 01, 2025
Twilight Dark-Adaptation Device Now Available in US
November 28, 2025
Global Myopia Awards
Advertisement
Latest Headlines
View More
December 16, 2025
Evaluation of AmblyoPlay® in Pediatric Anisometropic Amblyopia
December 02, 2025
FDA Approves Amneal’s Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye
December 02, 2025
FDA Approves Amneal’s Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye
December 01, 2025
Twilight Dark-Adaptation Device Now Available in US
November 28, 2025
Global Myopia Awards
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Trending Now
1
FDA Approves Amneal’s Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye
2
Digital Screen Time Increases Risk for Myopia
3
Belite Bio Reports Positive Phase 3 Results of Tinlarebant in Adolescents With Stargardt Disease
4
Eyedrops to Change Iris Color Under Scrutiny
5
Presbyopia Drop Gets FDA New Drug Application Approval
6
Lenz Announces Commercial Product Availability of Vizz in US
Conference Coverage
American Academy of Optometry annual meeting
November 01, 2024
Life-threatening eye signs and symptoms to keep on your radar
November 01, 2024
Visual field defect testing can be life saving
November 01, 2024
Facilitating dry eye disease management
ASCRS 2025
April 27, 2025
Office-Based Therapies Gain Ground in Glaucoma Care
April 26, 2025
Cataract Surgery in Patients With Corneal Disease
April 27, 2025